dr. mittendorf discusses cyclin e as a target in breast cancer
Published 11 years ago • 264 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
1:12
dr. mittendorf discusses immunotherapy efforts in breast cancer
-
1:24
dr. mittendorf on nelipepimut-s plus gm-csf in breast cancer
-
2:41
dr. mittendorf on peptide vaccines for the treatment of breast cancer
-
8:28
cdk4/6 inhibition in breast cancer
-
1:27
dr. elizabeth mittendorf on clinical trials exploring a new breast cancer vaccine
-
8:18
targeting cdk pathways in cancer treatment
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
1:20
dr. finn on new cdk 4/6 inhibitors for breast cancer
-
1:06
dr. finn on the potential of cdk inhibition
-
5:43
cdk 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer
-
7:14
ribociclib for hr advanced breast cancer
-
1:26
dr. geoffrey shapiro on the role of cdk2 in multiple breast cancer types
-
4:25
primary analysis of ae37 vaccine in breast cancer - dr. elizabeth mittendorf asco 2014
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
9:42
expert perspectives: rationale for cdk 4/6 inhibition in breast cancer
-
1:53
dr. finn on the inhibition of cdk 4/6 in breast cancer
-
25:25
cyclin-dependent kinases (cdk) 4/6 inhibitors in metastatic breast cancer
-
2:04
dr. finn on cyclin-dependent kinases and the treatment of cancer
-
30:17
ep7: cd33 as a therapeutic target in acute myeloid leukemia (aml)